Case series: Teriflunomide therapy in COVID-19 patients with MS

During the COVID-19 pandemic, patients with multiple sclerosis (MS) and their clinicians have had questions and concerns about whether immunotherapies for MS could influence risk for infection or lead to an unfavorable outcome. In the Journal of Neurology, Rohit Bakshi, MD, a senior neurologist at Brigham and Women’s Hospital, and international co-authors present the…

Details

University students facing food insecurity due to pandemic

Four out of ten university students have reported they are worried that they will run out of food as they deal with the impact of the coronavirus pandemic, according to a new report. A collaboration of universities in the UK and USA surveyed students on their levels of food insecurity during April, after universities in…

Details

Self-swabbing tests for COVID-19 accurate and safe, Stanford study reports

Test samples collected by people who swabbed their own nasal passages yielded results for the COVID-19 virus that were as accurate as samples collected by a health care worker, according to a small study by researchers at the Stanford University School of Medicine. The study was published June 12 in the Journal of the American…

Details

Up to 45 percent of SARS-CoV-2 infections may be asymptomatic

LA JOLLA, CA—An extraordinary percentage of people infected by the virus behind the ongoing deadly COVID-19 pandemic never show symptoms of the disease, according to the results of a Scripps Research analysis of public datasets on asymptomatic infections. The findings, published in Annals of Internal Medicine, suggest that asymptomatic infections may account for as much…

Details

Pandemics and the environment: China’s COVID-19 interventions reduced nitrogen dioxide levels

Pandemics and the Environment: China’s COVID-19 Interventions Reduced Nitrogen Dioxide Levels A new Special Collection of Science Advances papers will delve into how pandemics such as COVID-19 affect — and are affected by — global environmental conditions, underscoring the interconnectedness of global processes. «Economic lockdowns this year, designed to slow the spread of COVID-19, have…

Details

New algorithm uses artificial intelligence to help manage type 1 diabetes

Researchers and physicians at Oregon Health & Science University, using artificial intelligence and automated monitoring, have designed a method to help people with type 1 diabetes better manage their glucose levels. The research was published in the journal Nature Metabolism. «Our system design is unique,» said lead author Nichole Tyler, an M.D.-Ph.D. student in the…

Details

Parasites and the microbiome

Parasite infections are a constant presence for many people who live in tropical regions, particularly in less industrialized areas. These often chronic conditions are at best unpleasant; more seriously, children with parasite diseases that cause diarrhea can die of malnutrition or dehydration. In Genome Biology, a study led by University of Pennsylvania scientists investigated the…

Details

Face masks critical in preventing spread of COVID-19

A study by a team of researchers led by a Texas A&M University professor has found that not wearing a face mask dramatically increases a person’s chances of being infected by the COVID-19 virus. Renyi Zhang, Texas A&M Distinguished Professor of Atmospheric Sciences and the Harold J. Haynes Chair in the College of Geosciences, and…

Details

Study reveals impacts of climate change on migrating mule deer

When drought reshuffles the green-up of habitats that mule deer migrate across, it dramatically shortens the annual foraging bonanza they rely on. That is the main finding of a new University of Wyoming study, which shows the benefits of migration are likely to decrease for mule deer and other migratory herbivores as drought becomes more…

Details

Corrona Psoriasis Registry shares real-world evidence at AAD Virtual Meeting

Portland, Ore. (June 12, 2020) — The Corrona® Psoriasis Registry, a joint collaboration between the National Psoriasis Foundation, NPF, and Corrona, LLC, the leading sponsor of registries in immune-mediated diseases, announces that studies from the registry will be presented at the American Academy of Dermatology Virtual Meeting Experience (AAD VMX) taking place June 12-14, 2020.…

Details